Please provide your email address to receive an email when new articles are posted on . We are extremely fortunate to have a number of efficacious and relatively safe medical therapies to choose from ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
A growing evidence in the scientific literature suggests that oxidative damage plays a pathogenic role in primary open-angle glaucoma. Therefore, it is of interest to test whether drugs effective ...
Akums Drugs & Pharmaceuticals has announced the launch of a pioneering ripasudil+timolol combination therapy for glaucoma treatment. The DCGI-approved product represents a significant advancement in ...
We read this paper with interest. The study is an economic evaluation of topical antagonists and prostaglandin analogues for the treatment of glaucoma. It uses a Markov model to explore costs, and ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO -- A ...
IRVINE, Calif. - Allergan today announced that the U.S. Food and Drug Administration has approved COMBIGAN™ (brimonidine tartrate/timolol maleate ophthalmic ...
The Low-pressure Glaucoma Treatment Study [1,2,3] is a multicenter, double-masked, prospective, randomized clinical trial investigating visual field outcomes in patients with low-pressure glaucoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback